Delhi-based India IVF has secured a $1.25 million pre-Series A investment, marking the company’s first venture raise since launching in 2014. Tomorrow Capital, a Mumbai-based VC firm that backs early-stage healthtech startups, provided the funding.
“This partnership will empower us to expand our network and bring advanced fertility solutions to more communities. We look forward to making a positive impact on more families and growing India IVF into a trusted national brand,” said Dr. Somendra Shukla, Co-Founder and CEO of India IVF.
India IVF provides what it calls “tech-enabled” fertility care across five centers across North India. With the new funding, the company looks to expand throughout north India and offer fertility services to underserved communities with limited healthcare access.
“With a tech-enabled, patient-focused approach, [India IVF delivers] high-quality personalized care, addressing the often emotional and stigma-attached journey of the fertility treatment,” said Rahul Saha, Senior Principal at Tomorrow Capital, in a statement.
The $1.25 million investment from Tomorrow Capital follows growing interest in fertility care as infertility rates in India rise and the country’s IVF market continues to grow.
